Safety of the oral Factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF).
29 August 2022 (14:37 - 14:56)
Organised by:
Slides
About the speaker
Duke University Medical Center, Durham (United States of America)
3 More presentations in this session
Professor E. Marijon (Paris, FR)
Professor J. Ezekowitz (Edmonton, CA)
Doctor J. Delgado-Lista (Cordoba, ES)
Access the full session
The Event
ESC Congress 2022
29 August 2022
14:37 CET
You may be interested in
Congress Presentation
Congress Presentation
